Systemic Vasculitis clinical trials

The registry lists 31 studies for Systemic Vasculitis across more than 10 countries. 7 are recruiting or about to start. 6 of them are mainly about Systemic Vasculitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-08. Counting its 5 narrower conditions too, such as Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: 282 studies, 100 open.

Get an email when these change. Save the Systemic Vasculitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 14
Recruiting: 5
Status unknown: 4
Terminated: 3
Active, not recruiting: 3
Enrolling by invitation: 1

Phase

Phase 3: 6
Phase 2: 5
Phase 4: 5
Phase 1: 1

Where

United States: 12
France: 9
United Kingdom: 7
Canada: 5
Germany: 5
Brazil: 4

Who runs them

Assistance Publique - Hôpitaux de Paris (5) · University of South Florida (3) · Region Skane (2) · University of Pennsylvania (2) · University of Sao Paulo (2) · University of Sao Paulo General Hospital (1) · InflaRx GmbH (1) · Medical University of Warsaw (1)

What is being tested here

Drugs under test in Systemic Vasculitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Rituximab	1	0	2
Shingrix	1	0	1
Prednisone	0	1	1
Abatacept	0	1	1
Mepolizumab	0	1	1
Avacopan	0	0	1
13-valent pneumococcal vaccine	0	0	1
23-valent pneumococcal capsular polysaccharide vaccine	0	0	1
Vilobelimab	0	0	1
Glucocorticoid	0	0	1

Coming up

1phase 3 study under way

0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 5 Systemic Vasculitis studies recruiting now, 3 (60%) set no upper age limit and 2 (40%) stop at 75 or younger. 1 (20%) take children under 18. 1 (20%) are for women only and 0 (0%) for men only; 2 (40%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	1 (20%)	1 (20%)
18	5 (100%)	4 (80%)
30	4 (80%)	3 (60%)
40	4 (80%)	3 (60%)
50	4 (80%)	3 (60%)
65	3 (60%)	3 (60%)
75	3 (60%)	3 (60%)
85	3 (60%)	3 (60%)

Across all 31 studies, recruiting or not: 23% stop at 75 or younger and 19% at 65; 23% take children; 6% are for women only and 0% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 31 of 31. search them.